Invitae Corp at UBS Global Healthcare Conference Transcript

May 22, 2019 / 02:30PM GMT
Daniel Gregory Brennan - UBS Investment Bank, Research Division - Senior Equity Research Analyst of Healthcare Life Sciences

Great. So welcome, day 3, getting to the tail end of the UBS Global Healthcare Conference. Hopefully, everyone enjoyed it. My name is Dan Brennan. I cover tools, diagnostics and the pharma service space. Welcome.

With me on stage, very pleased to have Sean George, CEO of Invitae. We're going to have -- and also in the audience, we have Shelly Guyer, and we have Laura D'Angelo with the company.

So I have a long list of questions here, which we probably won't get through, but feel free, obviously. I'll look up halfway through and see if there's any questions from the audience, happy to entertain those.

Before we start, just -- I'll direct you to the UBS website at www.ubs.com where you can view the analyst disclaimer information.

So with that, Sean, welcome.

Sean E. George - Invitae Corporation - Co-Founder, President, CEO & Director

Thanks

Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis
30-Year Financial on one screen
All-in-one Stock Screener with unlimited filters
Customizable Stock Dashboard
Real Time Insider Trading Transactions
8,000+ Institutional investors’ 13F holdings
Powerful Excel Add-in and Google sheets Add-on
All data downloadable
Quick customer support
And much more...
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot